Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Munetaka Matoba

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
The Neuroradiology Journal|January 17, 2019
Pituitary macroadenoma: Accuracy of apparent diffusion coefficient magnetic resonance imaging in grading tumor aggressivenessMariko Doai, Hisao Tonami, Munetaka Matoba, et al.
Journal of Computer Assisted Tomography|July 30, 2003
Clinical and imaging findings of lymphoma in patients with Sjögren syndromeHisao Tonami, Munetaka Matoba, Yasuaki Kuginuki, et al.
Radiation Oncology (London, England)|February 7, 2023
Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and <sup>18</sup>F-FDG PET-CT for the prediction of outcomes of head and neck squamous cell carcinoma treated with chemoradiotherapyHirokazu Tsuchiya, Munetaka Matoba, Yuka Nishino, et al.
The Annals of Thoracic Surgery|May 31, 2011
Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancersKatsuo Usuda, Xi-Tong Zhao, Motoyasu Sagawa, et al.
Cancers|June 2, 2021
Whole-Lesion Apparent Diffusion Coefficient Histogram Analysis: Significance for Discriminating Lung Cancer from Pulmonary Abscess and Mycobacterial InfectionKatsuo Usuda, Shun Iwai, Aika Yamagata, et al.
Clinical Medicine Insights. Oncology|July 21, 2021
How to Discriminate Lung Cancer From Benign Pulmonary Nodules and Masses? Usefulness of Diffusion-Weighted Magnetic Resonance Imaging With Apparent Diffusion Coefficient and Inside/Wall Apparent Diffusion Coefficient RatioKatsuo Usuda, Shun Iwai, Aika Yamagata, et al.
Medical Oncology (Northwood, London, England)|April 11, 2018
FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factorsKatsuo Usuda, Aika Funasaki, Atsushi Sekimura, et al.
Cancers|August 7, 2021
Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and MassesKatsuo Usuda, Shun Iwai, Aika Yamagata, et al.
Cancers|April 3, 2021
Combination Assessment of Diffusion-Weighted Imaging and T2-Weighted Imaging Is Acceptable for the Differential Diagnosis of Lung Cancer from Benign Pulmonary Nodules and MassesKatsuo Usuda, Masahito Ishikawa, Shun Iwai, et al.
Cancers|June 20, 2019
Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural DiseasesKatsuo Usuda, Shun Iwai, Aika Funasaki, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The Neuroradiology Journal|January 17, 2019
Pituitary macroadenoma: Accuracy of apparent diffusion coefficient magnetic resonance imaging in grading tumor aggressivenessMariko Doai, Hisao Tonami, Munetaka Matoba, et al.
Journal of Computer Assisted Tomography|July 30, 2003
Clinical and imaging findings of lymphoma in patients with Sjögren syndromeHisao Tonami, Munetaka Matoba, Yasuaki Kuginuki, et al.
Radiation Oncology (London, England)|February 7, 2023
Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and <sup>18</sup>F-FDG PET-CT for the prediction of outcomes of head and neck squamous cell carcinoma treated with chemoradiotherapyHirokazu Tsuchiya, Munetaka Matoba, Yuka Nishino, et al.
The Annals of Thoracic Surgery|May 31, 2011
Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancersKatsuo Usuda, Xi-Tong Zhao, Motoyasu Sagawa, et al.
Cancers|June 2, 2021
Whole-Lesion Apparent Diffusion Coefficient Histogram Analysis: Significance for Discriminating Lung Cancer from Pulmonary Abscess and Mycobacterial InfectionKatsuo Usuda, Shun Iwai, Aika Yamagata, et al.
Clinical Medicine Insights. Oncology|July 21, 2021
How to Discriminate Lung Cancer From Benign Pulmonary Nodules and Masses? Usefulness of Diffusion-Weighted Magnetic Resonance Imaging With Apparent Diffusion Coefficient and Inside/Wall Apparent Diffusion Coefficient RatioKatsuo Usuda, Shun Iwai, Aika Yamagata, et al.
Medical Oncology (Northwood, London, England)|April 11, 2018
FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factorsKatsuo Usuda, Aika Funasaki, Atsushi Sekimura, et al.
Cancers|August 7, 2021
Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and MassesKatsuo Usuda, Shun Iwai, Aika Yamagata, et al.
Cancers|April 3, 2021
Combination Assessment of Diffusion-Weighted Imaging and T2-Weighted Imaging Is Acceptable for the Differential Diagnosis of Lung Cancer from Benign Pulmonary Nodules and MassesKatsuo Usuda, Masahito Ishikawa, Shun Iwai, et al.
Cancers|June 20, 2019
Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural DiseasesKatsuo Usuda, Shun Iwai, Aika Funasaki, et al.
Pageof 5